8/22/2016 | CV | Market Commentary: Morning Commentary: Convertibles quiet with summer slowdown in full swing; Illumina inactive
|
12/9/2015 | SP | New Issue: UBS prices $99,965 11.33% trigger yield optimization notes linked to Medivation
|
12/4/2015 | SP | New Issue: UBS prices $102,600 trigger phoenix autocallables linked to Medivation
|
12/3/2015 | SP | New Issue: UBS prices $200,000 airbag yield optimization notes tied to Medivation
|
10/26/2015 | BK | Medivation amends, restates $300 million credit agreement with JPMorgan
|
9/18/2015 | BK | Medivation borrows full $75 million under new revolving facility
|
9/9/2015 | BK | Medivation enters $75 million revolving credit facility via JPMorgan
|
7/22/2015 | SP | New Issue: Deutsche Bank sells $1.42 million 7% airbag autocallables on Medivation
|
7/15/2015 | SP | Deutsche Bank plans 6.5%-8.5% airbag autocallables linked Medivation
|
6/19/2015 | CVLM | Medivation to redeem all $167.7 million 2.625% convertibles due 2017
|
3/10/2015 | SP | New Issue: UBS prices $4.57 million 9.5% airbag autocallable yield notes linked to Medivation
|
3/6/2015 | SP | Market Commentary: UBS’ 8%-9.7% autocallable yield notes linked to Medivation receive high market risk score
|
3/5/2015 | CV | Market Commentary: NXP Semiconductors expands; Cheniere extends gains; Horizon Pharma deal looks ‘cheap’
|
3/4/2015 | SP | UBS plans 8%-9.7% airbag autocallable yield notes on Medivation
|
2/13/2015 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Medivation
|
2/5/2015 | SP | New Issue: UBS prices $1.65 million trigger phoenix autocallable optimization securities linked to Medivation
|
1/22/2015 | SP | New Issue: UBS prices $1.41 million airbag phoenix autocallables linked to Medivation
|
1/12/2015 | SP | UBS plans to price airbag phoenix autocallables linked to Medivation
|
12/9/2014 | SP | New Issue: JPMorgan prices $1 million 9.1% reverse exchangeables linked to Medivation
|
12/1/2014 | SP | New Issue: RBC prices $2.12 million buffered optimization notes tied to health care stocks
|
12/1/2014 | SP | New Issue: HSBC prices $5.26 million 9.5% airbag autocallable yield notes linked to Medivation
|
11/20/2014 | SP | HSBC plans 7.4%-9.4% airbag autocallable notes linked to Medivation
|
11/12/2014 | SP | New Issue: UBS prices $200,000 airbag yield optimization notes tied to Medivation
|
11/3/2014 | SP | New Issue: UBS prices $238,700 trigger phoenix autocallables linked to Medivation
|
10/28/2014 | SP | New Issue: UBS prices $300,000 trigger phoenix autocallables linked to Medivation
|
10/23/2014 | SP | New Issue: UBS prices $1.03 million trigger phoenix autocallable optimization securities linked to Medivation
|
10/3/2014 | SP | New Issue: UBS prices $188,980 trigger phoenix autocallables linked to Medivation
|
9/16/2014 | SP | New Issue: Barclays prices $2.32 million 9.3% airbag autocallables tied to Medivation
|
9/10/2014 | SP | Barclays to price 7.7%-9.7% airbag autocallables linked to Medivation
|
8/26/2014 | PP | Market Commentary: Priceline, Illumina trade in line; Medivation, Isis in focus; Prospect Capital bid lower
|
8/26/2014 | CV | Market Commentary: Priceline, Illumina trade in line; Medivation, Isis in focus; Prospect Capital bid lower
|
8/25/2014 | SP | New Issue: UBS prices $246,000 trigger phoenix autocallables linked to Medivation
|
8/20/2014 | SP | New Issue: UBS prices $140,000 trigger phoenix autocallables linked to Medivation
|
8/19/2014 | SP | New Issue: UBS prices $125,000 airbag yield optimization notes tied to Medivation
|
8/19/2014 | SP | New Issue: UBS prices $105,000 trigger phoenix autocallables linked to Medivation
|
8/19/2014 | SP | New Issue: RBC prices $9.92 million 10.5% airbag autocallables linked to Medivation
|
8/15/2014 | SP | New Issue: UBS prices $224,920 trigger phoenix autocallables linked to Medivation
|
8/13/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Medivation
|
8/12/2014 | SP | RBC plans 8.8%-10.8% airbag autocallable yield notes on Medivation
|
8/12/2014 | SP | New Issue: UBS prices $230,000 airbag yield optimization notes tied to Medivation
|
8/11/2014 | SP | New Issue: UBS prices $1 million contingent absolute return autocallables linked to Medivation
|
7/30/2014 | SP | New Issue: UBS prices $176,000 trigger phoenix autocallables linked to Medivation
|
7/22/2014 | SP | New Issue: UBS prices $323,000 trigger phoenix autocallables linked to Medivation
|
6/25/2014 | SP | New Issue: JPMorgan prices $2.21 million contingent absolute return autocallables linked to Medivation
|
6/16/2014 | SP | JPMorgan plans contingent absolute return autocallables on Medivation
|
6/16/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Medivation
|
5/28/2014 | SP | New Issue: UBS prices $200,000 contingent absolute return autocallables linked to Medivation
|
5/13/2014 | SP | New Issue: UBS prices $225,000 trigger phoenix autocallables linked to Medivation
|
5/9/2014 | SP | New Issue: UBS prices $155,000 airbag yield optimization notes tied to Medivation
|
4/30/2014 | SP | New Issue: UBS prices $110,000 trigger phoenix autocallables linked to Medivation
|
4/29/2014 | SP | New Issue: UBS prices $125,000 trigger phoenix autocallables linked to Medivation
|
4/28/2014 | SP | New Issue: UBS prices $325,000 trigger phoenix autocallables linked to Medivation
|
4/25/2014 | SP | New Issue: UBS prices $1 million trigger autocallables linked to Medivation
|
4/4/2014 | CV | Market Commentary: New 51job edges up from par despite lower shares; Genco shoots up on restructuring news
|
3/19/2014 | SP | New Issue: UBS prices $3.52 million contingent absolute return autocallables linked to Medivation
|
3/12/2014 | SP | UBS plans contingent absolute return autocallables linked to Medivation
|
3/11/2014 | SP | New Issue: UBS prices $5.6 million airbag yield optimization notes on Medivation
|
3/5/2014 | SP | UBS plans 9%-11% airbag yield optimization notes on Medivation
|
2/10/2014 | SP | New Issue: UBS prices $8.27 million 10.45% airbag autocallables linked to Medivation
|
2/5/2014 | SP | UBS to price 8.5%-10.5% airbag autocallables linked to Medivation
|
1/29/2014 | CV | Market Commentary: Fluidigm talk tightened; Medivation jumps on positive trial data; Illumina trades in line
|
12/17/2013 | SP | New Issue: UBS prices $3.31 million contingent absolute return autocallables linked to Medivation
|
12/11/2013 | SP | UBS plans contingent absolute return autocallables linked to Medivation
|
11/5/2013 | SP | New Issue: RBC prices $4.02 million airbag yield optimization autocallables on Medivation
|
10/31/2013 | SP | RBC to price 8.5%-10.5% airbag autocallables linked to Medivation
|
10/22/2013 | CV | Market Commentary: Midday Commentary: EMC lower, in line after earnings; Medivation sees positive drug trial news
|
10/22/2013 | CV | Market Commentary: Crown Castle tightens talk; United Technologies, EMC lower after earnings; Medivation flat
|
9/16/2013 | SP | New Issue: UBS prices $2.12 million contingent absolute return autocallables linked to Medivation
|
8/21/2013 | SP | New Issue: RBC prices $1.23 million 11% airbag yield optimization notes linked to Medivation
|
8/13/2013 | SP | New Issue: RBC prices $1.23 million airbag yield optimization notes on Medivation
|
8/6/2013 | SP | RBC plans 8.6%-11.6% airbag yield optimization notes on Medivation
|
7/31/2013 | SP | New Issue: JPMorgan prices $6.48 million 10.06% airbag autocallables linked to Medivation
|
7/24/2013 | SP | JPMorgan plans 8.85%-10.85% airbag autocallable notes on Medivation
|
6/17/2013 | CV | Market Commentary: Planned Extra Space reoffered, talk revised; Weyerhaeuser launches deal; Medivation eyed
|
4/5/2013 | CV | Market Commentary: New Colony puts in 'solid' debut; Heartware strong despite stock shock; Medivation in line
|
3/18/2013 | CV | Market Commentary: Medtronic convertibles trade flat; AMR steady to higher at 110 and change; Medivation dips
|
2/12/2013 | SP | New Issue: RBC prices $1.08 million airbag yield optimization notes on Medivation
|
2/4/2013 | SP | RBC plans to price 8.5%-10.5% airbag notes linked to Medivation
|
11/1/2012 | CV | Market Commentary: VeriSign expands on hedge, but most convertibles in line; Medivation erases early gains
|
7/3/2012 | CV | Market Commentary: Convertibles quiet ahead of holiday; Lincare, Theravance extend gains; U.S. Steel better
|
6/4/2012 | CV | Market Commentary: Convertibles see broad-based action; Dendreon down after rival's drug news; Salesforce steady
|
4/10/2012 | CV | Market Commentary: DFC Global prices $200 million; Prospect Capital launches; selling hits volatility names
|
3/26/2012 | CV | Market Commentary: Investment-grade issues dominate convertibles market; Medtronic higher; MF Global dips
|
3/16/2012 | CV | Market Commentary: Convertibles slightly weaker; Salix lower; Alliant Techsystems adds on hedge; DryShips up
|
3/15/2012 | CV | Market Commentary: Medivation treads water; Salix comes in on hedge since issue; Clearwire flat; Southwest adds
|
3/14/2012 | CV | New Issue: Medivation sells upsized $225 million five-year convertibles at 2.625%, up 43.5%
|
3/14/2012 | CV | Market Commentary: New Medivation, Wintrust edge higher; secondary quiet; overseas new issue market heats up
|
3/13/2012 | CV | Price talk on Medivation's $175 million of convertibles revised to 2.625%-3.125%, up 42.5%-45%
|
3/13/2012 | CV | Market Commentary: New Salix pops, then retreats on debut; Medivation talk revised; Wintrust notes to price
|
3/12/2012 | CV | Medivation to price $175 million five-year convertibles at 2.625%-3.125%, up 37.5%-42.5%
|
3/12/2012 | CV | Market Commentary: Salix Pharmaceuticals, Medivation to price; Suntech Power slips; Central European extends gains
|
3/12/2012 | CVHYPF | Medivation files automatic shelf covering debt, stock and preferreds
|
10/22/2008 | SS | Harbinger slashes stake by 7.3% in Medivation
|
6/23/2008 | PP | New Issue: Medivation settles $15 million private placement of shares
|
3/13/2008 | SS | Millenco reports 4% stake in Medivation
|
9/10/2007 | PP | New Issue: Medivation obtains $100 million equity line of credit
|
9/10/2007 | PP | Market Commentary: Sino Gas wraps $18.8 million placement; Medivation obtains $100 million equity line
|
8/3/2007 | CV | Medivation files automatic shelf registration
|
6/27/2007 | SP | New Issue: ABN Amro prices $1.2 million 25% knock-in notes linked to Medivation
|
6/19/2007 | SP | ABN Amro plans 25% Knock-in Reverse Exchangeables linked to Medivation
|
6/11/2007 | SS | Market Commentary: Medivation spikes; H&R Block props up Jackson Hewitt, Intuit; Ford up; Affiliated Computer up
|
12/8/2006 | PP | New Issue: Medivation secures $35.75 million from direct placement of stock
|
12/8/2006 | PP | Market Commentary: Medivation secures $35.75 million from stock sale; Questcor plans to close $13.9 million direct placement
|
10/19/2006 | BT | Medivation begins phase 1/2 trial of Dimebon for Huntington's disease, Alzheimer's disease extension trial
|
10/18/2006 | BT | Medivation files $30 million stock shelf
|
9/21/2006 | BT | Medivation's phase 2 study of Dimebon for Alzheimer's meets all five endpoints
|
5/16/2006 | PP | Market Commentary: Medivation to wrap $14.25 million deal; Accentia Biopharmaceuticals to settle $8.23 million PIPE
|
5/16/2006 | BTPP | New Issue: Medivation will settle $14.25 million direct placement of shares
|
5/12/2006 | BTPP | Medivation plans direct placement of 3 million shares
|
3/8/2006 | BT | Medivation common stock approved for listing on Amex
|
3/1/2006 | BT | Medivation says FDA will require additional toxicology testing, may delay trials
|
12/19/2005 | BT | Medivation greenshoe exercised, raising follow-on offering to 5.64 million shares
|
10/11/2005 | BT | Medivation to sell 8.7 million shares via Adams Harkness
|
12/20/2004 | PP | New Issue: Orion Acquisitions raises $12 million in private placement of shares
|
12/20/2004 | PP | Market Commentary: Private placement volume improves despite shaky stocks; Interchange raises $15 million
|